Yuhan Corp. posted record-breaking third-quarter results, with revenue reaching 598.8 billion won and operating profit ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

Appointed Douglas Williams, Ph.D. as Chair of the Board of DirectorsFDA Clearance of Investigational New Drug Application (IND) for systemic ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

TG Therapeutics, Inc. reported a modest Q3 beat and raised the full-year net sales guidance range for Briumvi by $7.5 million ...

TG Therapeutics' Q3 earnings missed EPS expectations despite Briumvi's revenue growth. See why TGTX stock is a Buy.

Alexander's Inc (ALX) is expected to report for 3Q. Algoma Central Corp (ALC.T) is expected to report for 3Q. BioCryst Pharmaceuticals Inc (BCRX) is expected to report $-0.07 for 3Q.

We recently compiled a list of the 10 Stocks Set to Explode in 2025. In this article, we are going to take a look at where TG ...

While the TG EAPCET 2024 notification was issued on February 21 with exams held from May 7 to 11, the admissions for the pharmacy, biotechnology and agriculture, and allied branches were underway.